Erlanger Cardiology Performs Tennessee’s First Atrial Leadless Pacemaker Implant

Chattanooga, Tenn. – On April 17, Harish Manyam, MD, Chief of Cardiology at Erlanger and Chair of Medicine for the University of Tennessee Health Science Center College of Medicine – Chattanooga, completed Tennessee’s first atrial leadless pacemaker implantation. Erlanger is the first hospital in Tennessee to use the world’s first dual chamber leadless pacemaker system. …

Erlanger Gastroenterology Team Instrumental to International Study Success, Publication

Chattanooga, Tenn - In partnership with Erlanger, researchers at the University of Tennessee Health Science Center College of Medicine – Chattanooga were part of a major multicenter international study just published in the journal Lancet Digital Health. The study evaluated the effectiveness of a new Artificial Intelligence (AI) system for detecting polyps in screening and surveillance colonoscopy. Arslan …

Erlanger Urology Completes Milestone 50th Breakthrough Procedure for Prostate Cancer

Chattanooga, Tenn. – On February 9, Erlanger Urology, a regional leader for prostate cancer and kidney-sparing surgeries, performed the 50th Robotic Focal High Intensity Focused Ultrasound (HIFU) procedure. Dr. Amar Singh, Urological Oncologist, performed the milestone procedure. Erlanger Urology has the first and only two doctors in the state of Tennessee who perform these groundbreaking procedures for …

Erlanger Urologist Dr. Waldorf becomes Second in Tennessee to Perform Breakthrough Procedure for Prostate Cancer

Chattanooga, Tenn. – On August 17, 2023, Dr. Benjamin Waldorf, Erlanger Urologist, performed his first noninvasive Focal One Robotic High Intensity Focused Ultrasound (HIFU) procedure for prostate cancer. Erlanger Urology, a regional leader for prostate cancer and kidney-sparing surgeries, remains the first and only center in Tennessee to offer Focal One Robotic HIFU. Focal One Robotic HIFU …

Erlanger Gynecologic Surgeon First in Region to Perform New Minimally Invasive Surgery for Fibroids

Chattanooga, Tenn. – On March 20, Dr. Mitch Dizon, a subspecialist in Minimally Invasive Gynecologic Surgery at Erlanger Women’s Health, performed the region’s first laparoscopic radiofrequency ablation surgery for uterine fibroids. According to national statistics, approximately 540,000 hysterectomies are performed annually for non-cancerous conditions, including uterine fibroids. Erlanger now offers another safe and effective minimally invasive option …

LIFE FORCE Becomes First Air Medical Transport Provider in Tennessee to offer High Flow Oxygen Therapy Capabilities

Chattanooga, Tenn. - LIFE FORCE is excited to announce its newest capability of offering high flow oxygen therapy to patients during air medical transports. They are the first air medical team in the state of Tennessee to offer this therapy. High flow oxygen therapy, primarily used in a hospital setting, helps reduce the need for …

Erlanger Health System Receives Orthopedic Center of Excellence Designation from DNV – First in Tennessee

[Chattanooga, Tenn., November 2, 2022] — Erlanger Health System announces receipt of the Orthopedic Center of Excellence Designation from DNV. This designation affirms an organization’s excellence in the provision of diagnostic services, surgical services, and therapies related to orthopedic care. “This earned designation is a testament to the dedication and expertise of the Erlanger Orthopaedics …

Erlanger’s LIFE FORCE utilizes new Ventilation Therapy for COVID-19 Patients

A LIFE FORCE crew member demonstrates how the hood ventilation system works. Chattanooga, Tenn. – LIFE FORCE Air Medical, Erlanger Health System’s air medical program has a new tool onboard to care for the most critically ill COVID-19 patients. The ventilation therapy hood, was first used in Italy to provide COVID-19 patients a comfortable alternative …

Erlanger Heart and Lung Institute first in the country to implant new defibrillator

Chattanooga, Tenn. – The Erlanger Heart and Lung Institute announces Dr. Harish Manyam has successfully performed the first procedure in the country to implant a unique dual chamber implantable cardioverter defibrillator (ICD). The same day, he was also the first in the country to implant a single chamber ICD. This latest advancement features compatibility with …

Erlanger stroke program gains international recognition in Wall Street Journal

Breakthrough innovations in stroke treatment at the Chattanooga-based Erlanger Health System received international recognition in Tuesday’s issue of the Wall Street Journal.  The business-focused newspaper published two articles May 14 showcasing the latest technologies in treating stroke which were developed at Erlanger.  The lead article, titled “New Technology Promises to Speed Clinical Treatment for Stroke,” …